Rhumbline Advisers Genfit S.A. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Genfit S.A. stock. As of the latest transaction made, Rhumbline Advisers holds 678 shares of GNFT stock, worth $3,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
678
Previous 678
-0.0%
Holding current value
$3,057
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GNFT
# of Institutions
9Shares Held
209KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny131KShares$592,9880.0% of portfolio
-
Morgan Stanley New York, NY25.5KShares$115,0950.0% of portfolio
-
Old Mission Capital LLC22.2KShares$100,2930.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P713.2KShares$59,3290.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.3KShares$55,6120.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $225M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...